Amoeba SA (FR:ALMIB) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Koppert, a leader in biological crop protection, and Amoéba, a greentech company, have signed a Memorandum of Understanding to jointly launch a groundbreaking biofungicide named AXPERA. This partnership aims to enhance sustainable agriculture by utilizing Amoéba’s innovative amoeba-based solution to combat fungal diseases. The collaboration will focus on distribution, production, and regulatory approvals, with AXPERA expected to hit the European market by the end of 2025.
For further insights into FR:ALMIB stock, check out TipRanks’ Stock Analysis page.